Market Overview

UPDATE: Sterne Agee Upgrades Intuitive Surgical on More Balanced Risk/Reward

Related ISRG
Early Global News: Mali Radisson Attack, Depomed-Horizon Fallout, EU Cracking Down On Bitcoin
Benzinga's Top Initiations

In a report published Tuesday, Sterne Agee analyst Gregory P. Chodaczek upgraded the rating on Intuitive Surgical (NASDAQ: ISRG) from Underperform to Neutral, and raised the price target from $360.00 to $380.00.

In the report, Sterne Agee noted, “With ISRG shares down approximately 31% from its 2014 high, following a disappointing 1Q14 report, we are upgrading the stock to Neutral from Underperform as we view the risk/reward as more balanced at current levels. While we still believe dVH procedures volumes in the U.S. will be lower than 2013 and the da Vinci Xi roll out will be modest, we think the stock's current valuation has priced in these negative scenarios.”

Intuitive Surgical closed on Monday at $367.80.

Latest Ratings for ISRG

Nov 2015CitigroupInitiates Coverage onBuy
Jul 2015Canaccord GenuityUpgradesBuy
Jul 2015BarclaysMaintainsOverweight

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: Gregory P. Chodaczek Sterne AgeeAnalyst Color Upgrades Analyst Ratings


Related Articles (ISRG)

Get Benzinga's Newsletters